Systasy Bioscience GmBH
Munich, Germany systasy.de From their website, Nov 2026
Work here? Claim this listing
About
Systasy Bioscience GmbH provides hyper-multiplexed drug discovery solutions for complex diseases, with a focus on brain disorders, for pharmaceutical and biotech partners. It also offers patient-derived human disease models, pathway-based screening, viral tropism profiling for gene therapy development, and single-cell/nucleus RNA sequencing services. The company is headquartered in Munich/Planegg, Germany.
Services
Pathway Based Drug Discovery
Uses highly multiplexed pathway activity screens with patient-derived human disease models to identify disease pathways, therapeutic targets, and support hit identification and lead optimization.
targetFinder
Combines RNAi or CRISPR/Cas9 libraries with optimized sensors to measure the roles of individual genes in signaling networks.
pathwayPROFILER
Measures the activities of various disease-relevant target classes in living cells.
safetyProfiler
A multiplexed cell-based assay platform for drug safety profiling that reveals efficacy, potency, and side effects of drugs.
Single-Cell/Nucleus RNA Sequencing
Provides an end-to-end workflow from sample processing and library preparation through sequencing, data analysis, and reporting.
Genomics & sequencing
Human Disease Models
Develops and uses patient-derived human disease models for multiplexed pathway analysis and compound screening.
Viral Tropism profiling
Offers profiling technology to support viral vector development for gene therapy.
Barcoding Technology
Uses proprietary DNA barcoding technology for highly multiplexed transcriptomic and pathway analysis at the single-cell level.
1 more services
- Single-Cell Transcriptomics
- What to send
- Sample processing from complex and difficult-to-dissociate tissues
- Cells or nuclei for single-cell/single-nucleus workflows
Capabilities
- Assays and studies
- NGS
- High-content imaging
- Cell-based assays
- Multiplexed pathway activity screens
- Drug safety profiling
- Phenotypic screening
13 more
- Mechanism-of-action (MOA) analysis
- Compound screening
- Lead optimization
- Dose-response profiling
- Single-cell RNA-seq
- Single-nucleus RNA sequencing
- Transcriptomic analysis
- Highly multiplexed pathway activity screens
- High-content phenotypic profiling
- Single-cell RNA sequencing
- Viral tropism profiling
- Biomarker identification
- Patient stratification
- Scale and capacity
- Up to 30 major cellular signaling pathways captured in parallel
- Millions of molecular barcodes
- More than 100 individual signaling events
- Seven major signaling clusters
- Therapeutic areas
- Brain disorders
- Neutrophil-derived inflammatory diseases
- Neuroscience
- Cancer
- Immunology
- Developmental biology
Instruments and platforms
- Next-generation sequencing (NGS) platforms
Modalities and species
- Modalities
- Viral vector
- Cell therapy
- Gene editing
- Species and models
- Human disease models
- Human neuronal 2D models
- Human 3D models
- Cell lines
- Murine models
- iPSC-based human disease models
7 more
- Patient-derived cellular model systems
- Neuroscience
- Cancer
- Immunology
- Developmental biology
- Patient-derived human disease models
- Cell-based assays
Industries served
- Pharmaceutical
- Biotech
- Gene therapy
Details
- Founded
- 2012
- Office
- Fraunhoferstraße 8, 82152 Planegg
- Sites
- Planegg, Germany
- Martinsreid, Germany
- Göttingen, Germany
- Phone
- +49 (0) 89 - 9442 5775